HIV policy: the path forward--a joint position paper of the HIV Medicine Association of the Infectious Diseases Society of America and the American College of Physicians.
نویسندگان
چکیده
Christine Lubinski, Judith Aberg, Arlene D. Bardeguez, Richard Elion, Patricia Emmanuel, Daniel Kuritzkes, Michael Saag, Kathleen E. Squires, Andrea Weddle, Jennifer Rainey, M. Renee Zerehi, J. Fred Ralston, David A. Fleming, David Bronson, Molly Cook, Charles Cutler, Yul Ejnes, Robert Gluckman, Mark Liebow, Kenneth Musana, Mark E. Mayer, Mark W. Purtle, P. Preston Reynolds, Lavanya Viswanathan, Kevin B. Weiss, and Baligh Yehia HIV Medicine Association, Infectious Diseases Society of America, Arlington, University of Virginia, Charlottesville, and Virginia Commonwealth University, Glen Allen, Virginia; Bellevue Hospital Center, New York University Medical School, New York, New York; University of Medicine and Dentistry–New Jersey Medical School, Newark; Elizabeth Taylor Medical Center and American College of Physicians, Washington, DC; University of South Florida, Tampa; Brigham and Women’s Hospital, Harvard Medical School, Cambridge, Massachusetts; University of Alabama at Birmingham, Birmingham; Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania; Halle T. Debas Academy of Medical Educators, University of California, San Franscisco; Fayetteville Medical Associates, Fayetteville, Tennessee; University of Missouri Center for Health Ethics, University of Missouri School of Medicine, Columbia; Cleveland Clinic Medicine Institute and General Internal Medicine, Cleveland Clinic, Cleveland, Ohio; Coastal Medical, Cranston, Rhode Island; Graduate Medical Education Clinics, Providence Physician Division, Portland, Oregon; Mayo Clinic, Rochester, Minnesota; Central Iowa Hospital Corporation, Des Moines; American Board of Medical Specialists, Evanston, Illinois; and Johns Hopkins University, Baltimore, and Uniformed Services University of the Health Services, Bethesda, Maryland
منابع مشابه
Improving the Quality and Quantity of HIV Data in the Middle East and North Africa: Key Challenges and Ways Forward
Although the HIV pandemic is witnessing a decline in the number of new infections in most regions of the world, the Middle East and North Africa (MENA) has a rapidly growing HIV problem. While generating HIV data has been consistently increasing since 2005, MENA’s contribution to the global HIV literature is just over 1% and the existing evidence often falls behind the academic standards. Sever...
متن کاملLack of Association between Interleukin-10 Gene Promoter Polymorphisms with HIV Susceptibility and Progression to AIDS
Background & Objective: Interleukin (IL)-10 is an important anti-inflammatory and immunomodulatory cytokine. Some authors believe that single nucleotide polymorphisms (SNP) in the promoter region of the IL-10 gene have been associated with susceptibility to HIV infection and progression to AIDS, but its role is not clearly defined yet. The present study was undertaken to evaluate the a...
متن کاملA suitable data model for HIV infection and epidemic detection
Background: In recent years, there has been an increase in the amount and variety of data generated in the field of healthcare, (e.g., data related to the prevalence of contagious diseases in the society). Various patterns of individuals’ relationships in the society make the analysis of the network a complex, highly important process in detecting and preventing the incidence of diseases....
متن کاملAn Analysis of the Extent of Social Inclusion and Equity Consideration in Malawi’s National HIV and AIDS Policy Review Process
Background Equity and social inclusion for vulnerable groups in policy development processes and resulting documents remain a challenge globally. Most often, the marginalization of vulnerable groups is overlooked in both the planning and practice of health service delivery. Such marginalization may occur because authorities deem the targeting of those who already have better access to healthcar...
متن کاملSuccessful Desensitization Efavirenz in 8 -year-Old HIV-Positive Child
Background & Aims: Allergic reaction is a common side effect of Efavirenz and drug replacement may not be an option to physicians. Here, a successful drug desensitization experiment on an 8-year-old female child over a period of 9 days is reported. Case presentation: The patient was an 8-year old female child with HIV in Kerman, Iran who had been received oral efavirenz together with lamivudine...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
دوره 48 10 شماره
صفحات -
تاریخ انتشار 2009